See also this year's filing and all EDGAR filings for this company.
PDF Report 0001556263_2019_Syros_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001556263, Syros Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,734,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,861,000 |
| 3 | remainder_Assets | 1,171,000 |
| 4 | LiabilitiesCurrent | 19,529,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,164,000 |
| 9 | ResearchAndDevelopmentExpense | 50,182,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,050,000 |
| 12 | remainder_NetIncome | 2,017,000 |
| 13 | remainder_ComprehensiveNetIncome | 39,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 106,766,000 |
| 1 | Liabilities | 19,529,000 |
| 2 | Expenses | 66,346,000 |
| 3 | Revenues | 2,050,000 |
| 4 | StockholdersEquity | 87,237,000 |
| 5 | NetIncome | -62,279,000 |
| 6 | ComprehensiveNetIncome | -62,259,500 |
| 7 | BaseVar | 98,373,500 |
| 8 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
